On a disclosed annual basis, revenue rose from KRW 165 million (converted) in the fiscal year ended June 2023 to KRW 24.2 billion in the year ended June 2026, growing for three consecutive fiscal years since the year ended June 2024.
The year ended June 2026 is the largest year in the period from June 2023 to June 2026. The sharp increase in the year ended June 2025 was reported to reflect wider recognition of milestone income following the European marketing authorization for TUZNUE, and growth slowed to 76.1% in the year ended June 2026.
Over the same span, operating losses were KRW 70.8 billion, KRW 63.4 billion, KRW 64.6 billion and KRW 86.8 billion, marking four consecutive fiscal years of operating losses, with the largest loss in the year ended June 2026.
Cost of sales rose 52.2% year on year and R&D expenses more than doubled, and a report based on the business report read this as revenue growth failing to keep pace with costs (Junggi Economy).
The operating margin improved to -359.1% from -9,111.2% and -470.1% in the two prior years, but losses remain large relative to sales. Net income attributable to controlling shareholders swung from a KRW 21.4 billion profit in the year ended June 2025 back to a net loss of KRW 84.9 billion in the year ended June 2026.
Net loss including non-controlling interests was KRW 114 billion in the latest year, with the report citing higher other expenses and finance costs as the main drivers. Operating cash flow was negative in all four years, at -KRW 61.3 billion, -KRW 48.5 billion, -KRW 50 billion and -KRW 51.8 billion.
Quarterly revenue swung widely, from KRW 5.3 billion in Q2 2025 to KRW 2.24 billion in Q3, KRW 7.31 billion in Q4, KRW 478 million in Q1 2026 and KRW 14.2 billion in Q2 2026, all converted from USD.
The net loss attributable to controlling shareholders of KRW 39.3 billion in Q2 2026 was the largest quarterly figure in the disclosed period, and the four quarters from Q3 2025 to Q2 2026 total KRW 84.9 billion in net losses attributable to controlling shareholders.